NCT06825260View on ClinicalTrials.gov

PEG3350 vs Senna After Urogyn Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

254

Participants

Timeline

Start Date

April 23, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

July 31, 2027

Conditions
Obstructive Defecation SyndromePostoperative Constipation
Interventions
DRUG

Senna

Senna, oral, 8.6mg, 2 tablets daily (up to 4 tablets twice a day) for 7 days

DRUG

Polyethylene glycol 3350

Polyethylene Glycol 3350, oral, 17g, daily for 7 days

Trial Locations (1)

13203

RECRUITING

St. Joseph's Health Hospital, Syracuse

All Listed Sponsors
lead

St. Joseph's Health, New York

OTHER